Home LiteratureArticle Details
该文献已被撤稿(Retracted Publication),引用前请核实。
PMID: 22105604 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Retracted Publication

Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).

Molecular medicine (Cambridge, Mass.) ·Vol. 18 ·2012-03-30 ·Pages 250-9

Yang H, Lundbäck P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, Antoine DJ

Abstract

High mobility group box 1 (HMGB1) is a nuclear protein with extracellular inflammatory cytokine activity. It is released passively during cell injury and necrosis, and secreted actively by immune cells. HMGB1 contains three conserved redox-sensitive cysteine residues: C23 and C45 can form an intramolecular disulfide bond, whereas C106 is unpaired and is essential for the interaction with Toll-Like Receptor (TLR) 4. However, a comprehensive characterization of the dynamic redox states of each cysteine residue and of their impacts on innate immune responses is lacking. Using tandem mass spectrometric analysis, we now have established that the C106 thiol and the C23-C45 disulfide bond are required for HMGB1 to induce nuclear NF-κB translocation and tumor necrosis factor (TNF) production in macrophages. Both irreversible oxidation to sulphonates and complete reduction to thiols of these cysteines inhibited TNF production markedly. In a proof of concept murine model of hepatic necrosis induced by acetaminophen, during inflammation, the predominant form of serum HMGB1 is the active one, containing a C106 thiol group and a disulfide bond between C23 and C45, whereas the inactive form of HMGB1, containing terminally oxidized cysteines, accumulates during inflammation resolution and hepatic regeneration. These results reveal critical posttranslational redox mechanisms that control the proinflammatory activity of HMGB1 and its inactivation during pathogenesis.

MeSH Terms
Acetaminophen/toxicity Analgesics, Non-Narcotic/toxicity Animals Cell Line Chemical and Drug Induced Liver Injury/etiology,metabolism Cysteine/metabolism HMGB1 Protein/chemistry,genetics,metabolism Humans Macrophages/metabolism Male Mice Oxidation-Reduction Transcription Factor RelA/metabolism Tumor Necrosis Factor-alpha/metabolism
Chemicals
Analgesics, Non-Narcotic HMGB1 Protein Transcription Factor RelA Tumor Necrosis Factor-alpha Acetaminophen Cysteine
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Yang Huan
Laboratory of Biomedical Science, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America.
Lundbäck Peter
Ottosson Lars
Erlandsson-Harris Helena
Venereau Emilie
Bianchi Marco E
Al-Abed Yousef
Andersson Ulf
Tracey Kevin J
Antoine Daniel J
References (24)
24 references, click to expand
  1. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1.
    Exp Cell Res. 2006 Nov 1;312(18):3526-38 PMID: 16962095
  2. Structural basis for the proinflammatory cytokine activity of high mobility group box 1.
    Mol Med. 2003 Jan-Feb;9(1-2):37-45 PMID: 12765338
  3. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.
    J Exp Med. 2000 Aug 21;192(4):565-70 PMID: 10952726
  4. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.
    Immunity. 2008 Jul 18;29(1):21-32 PMID: 18631454
  5. Specific recognition of cruciform DNA by nuclear protein HMG1.
    Science. 1989 Feb 24;243(4894 Pt 1):1056-9 PMID: 2922595
  6. Redox remodeling: a candidate regulator of HMGB1 function in injured skeletal muscle.
    Ann N Y Acad Sci. 2010 Oct;1209:83-90 PMID: 20958320
  7. Recombinant HMGB1 with cytokine-stimulating activity.
    J Immunol Methods. 2004 Jun;289(1-2):211-23 PMID: 15251426
  8. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
    Biochemistry. 2011 Apr 5;50(13):2567-74 PMID: 21355578
  9. Redox properties of the A-domain of the HMGB1 protein.
    FEBS Lett. 2008 Dec 10;582(29):3973-8 PMID: 18996119
  10. Disulfide bonds as switches for protein function.
    Trends Biochem Sci. 2003 Apr;28(4):210-4 PMID: 12713905
  11. Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.
    Mol Med. 2010 Nov-Dec;16(11-12):479-90 PMID: 20811657
  12. Endogenous HMGB1 regulates autophagy.
    J Cell Biol. 2010 Sep 6;190(5):881-92 PMID: 20819940
  13. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.
    Nature. 2002 Jul 11;418(6894):191-5 PMID: 12110890
  14. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.
    EMBO J. 2003 Oct 15;22(20):5551-60 PMID: 14532127
  15. HMG-1 as a late mediator of endotoxin lethality in mice.
    Science. 1999 Jul 9;285(5425):248-51 PMID: 10398600
  16. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
    J Leukoc Biol. 2009 Sep;86(3):655-62 PMID: 19564572
  17. High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo.
    Toxicol Sci. 2009 Dec;112(2):521-31 PMID: 19783637
  18. Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models.
    Mol Med. 2011 Sep-Oct;17(9-10):1039-44 PMID: 21666956
  19. Introduction: HMGB1 in inflammation and innate immunity.
    J Intern Med. 2011 Oct;270(4):296-300 PMID: 21793949
  20. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox.
    Trends Immunol. 2007 Oct;28(10):429-36 PMID: 17845865
  21. Protein oxidation: role in signalling and detection by mass spectrometry.
    Amino Acids. 2012 Jan;42(1):5-21 PMID: 20401673
  22. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.
    Science. 2009 Mar 27;323(5922):1722-5 PMID: 19264983
  23. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.
    Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11942-7 PMID: 20547845
  24. Tail-mediated collapse of HMGB1 is dynamic and occurs via differential binding of the acidic tail to the A and B domains.
    J Mol Biol. 2010 Nov 12;403(5):706-22 PMID: 20691192
Article Info
Journal
Molecular medicine (Cambridge, Mass.)
Abbr.
Mol Med
ISSN
1528-3658
Published
2012-03-30
Epub
2012-00-30
Pages
250-9
Language
English
Region
England
NLM ID
9501023
PMCID
PMC3324950
Subset
IM
Grants
NIGMS NIH HHS · R01 GM057226 · United States
NCRR NIH HHS · M01 RR018535 · United States
NCRR NIH HHS · M01RR018535 · United States
NIGMS NIH HHS · GM098446 · United States
Medical Research Council · G0700654 · United Kingdom
NIGMS NIH HHS · R01 GM098446 · United States
Corrections
ExpressionOfConcernIn
RetractionIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com